Bristol Myers Squibb (BMS) has shared positive top-line results from two late-stage studies of its oral TYK2 inhibitor Sotyktu (deucravacitinib) in adults with active psoriatic arthritis (PsA). The ...

Axsome Therapeutics has announced that it has successfully completed its late-stage clinical programme evaluating investigational AXS-05 (dextromethorphan-bupropion) in Alzheimer’s disease (AD) ...

Kearney Urology Center in the US has reported a 50% reduction in biopsies since adopting a new prostate cancer blood test with “unprecedented accuracy”. The test, EpiSwitch PSE, is the culmination of ...

Amgen’s Imdylltra (tarlatamab) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) to treat adults with small cell lung cancer (SCLC). The drug has been specifically ...

Gower is recognised as one of the world’s leading publishers of specialist business and management books and resources. Our publishing programme covers many of the main business processes and ...

Novartis has shared positive top-line results from a late-stage study of its investigational gene therapy in patients aged two to less than 18 years with the rare neuromuscular disease spinal muscular ...

BeiGene’s PD-1 inhibitor Tevimbra (tislelizumab-jsgr) has been granted approval by the US Food and Drug Administration (FDA) as part of a first-line combination treatment for advanced gastric cancer.

CHCR is a research centre offering healthcare communication consultancy, professional development and training including the first UK Postgraduate Certificate in Health Communications.

Malana research consult international (MARECI) is an independent full-service market and social Research agency, operating across East African Sub- Region with head office in Kampala, Uganda. Malana ...

Our broad arsenal of services and solutions now spans the entire value chain. By expanding the methodologies of MarketRx, a highly respected firm acquired in 2007, our offerings now include: ...